SGMOQ
SANGAMO THERAPEUTICS, INC
-0.01 (-3.40%)0.14USD216K成交股數60.0M市值–本益比(近四季)1.7股價營收比-77.6%營收年增(近四季)2026-09-28下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 | 22Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 1.4M-81% | 581K-99% | 18.3M+5042% | 6.4M+1238% | 7.6M-20% | 49.4M+623% | 356K-100% | 481K-98% | 9.4M | 6.8M | 158M | 27.2M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 26.6M | 28.1M | 27.1M | 26.0M | 23.7M | 27.7M | 24.2M | 35.9M | 57.1M | 63.0M | 63.2M | 66.2M |
| 銷售管理費用 | 6.8M | 8.0M | 9.1M | 10.1M | 9.9M | 11.0M | 12.0M | 11.8M | 13.9M | 16.0M | 18.1M | 16.4M |
| 營業利益 | −31.9M+23% | −35.6M-434% | −17.9M-52% | −29.6M-42% | −26.0M-76% | 10.6M-109% | −37.1M-306% | −51.5M-7% | −106M | −124M | 18.0M | −55.4M |
| 營業利益率 | -2,215.4% | -6,119.3% | -97.5% | -460.3% | -344.2% | 21.5% | -10,416.9% | -10,712.3% | -1,132.2% | -1,807.9% | 11.4% | -203.4% |
| 稅後淨利 | −31.0M+32% | −34.9M-427% | −20.0M-45% | −30.6M-38% | −23.4M-78% | 10.7M-109% | −36.1M-271% | −49.1M-6% | −104M | −115M | 21.1M | −52.0M |
| 淨利率 | -2,149.4% | -6,012.0% | -109.2% | -475.3% | -309.8% | 21.6% | -10,148.3% | -10,205.6% | -1,108.4% | -1,675.3% | 13.4% | -190.9% |
| 稀釋 EPS | -0.080% | -0.11-375% | -0.08-56% | -0.14-48% | -0.08-86% | 0.04-106% | -0.18-250% | -0.27-16% | -0.59 | -0.66 | 0.12 | -0.32 |
| 稀釋股數 | 390M | 304M | 257M | 220M | 202M | 214M | 204M | 180M | 177M | 174M | 169M | 154M |
資產負債表 期末餘額
| 科目 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 | 22Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 27.6M | 29.6M | 38.3M | 25.2M | 41.9M | 39.2M | 27.8M | 54.4M | 56.5M | 66.8M | 78.2M | 100M |
| 應收帳款 | 873K | 523K | 372K | 366K | 526K | 10.5M | 581K | 691K | 1.1M | 2.7M | 7.0M | 3.7M |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 60.0M | 88.6M | 97.6M | 86.2M | 102M | 111M | 93.0M | 129M | 220M | 325M | 441M | 563M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 78.9M | 82.4M | 78.0M | 81.3M | 78.9M | 72.1M | 69.3M | 72.3M | 84.8M | 91.4M | 105M | 268M |
| 股東權益 | −19.0M | 6.2M | 19.6M | 4.9M | 22.8M | 39.1M | 23.7M | 56.7M | 135M | 234M | 336M | 295M |
| 負債比 | 131.6% | 93.0% | 79.9% | 94.3% | 77.6% | 64.8% | 74.5% | 56.0% | 38.6% | 28.1% | 23.8% | 47.6% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 | 22Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | −19.3M | – | – | −26.1M-46% | – | – | – | −48.7M | – | – | −66.3M | – |
| 資本支出 | 13K | – | – | 0 | – | – | – | 0 | – | – | 10.2M | – |
| 自由現金流 | −19.3M | – | – | −26.1M-46% | – | – | – | −48.7M | – | – | −76.5M | – |
| 折舊攤銷 | 719K | – | – | 1.0M | – | – | – | 1.4M | – | – | 3.5M | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | -1,338.1% | – | – | -406.2% | – | – | – | -10,117.0% | – | – | -48.4% | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 39.6M
| Reportable | 39.6M | 100.0% | -31.6% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 39.6M | -31.6% | −123M | -310.8% | -0.44 | −97.3M |
| FY2024 | 57.8M | -67.2% | −97.9M | -169.4% | -0.49 | −67.4M |
| FY2023 | 176M | +58.3% | −258M | -146.3% | -1.48 | −246M |
| FY2022 | 111M | +0.5% | −192M | -172.8% | -1.25 | −244M |
| FY2021 | 111M | -6.3% | −178M | -161.1% | -1.23 | −257M |
| FY2020 | 118M | +15.4% | −121M | -102.4% | -0.90 | 155M |
| FY2019 | 102M | +21.3% | −95.2M | -92.9% | -0.85 | −165M |
| FY2018 | 84.5M | – | −68.3M | -80.9% | -0.70 | −6.5M |